Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now
XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist.
Earnings Estimates Moving Higher for Dentsply (XRAY): Time to Buy?
Dentsply (XRAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now?
XRAY or COO: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Dentsply International (XRAY) and The Cooper Companies (COO). But which of these two stocks presents investors with the better value opportunity right now?
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dentsply (XRAY) Reliance on International Sales: What Investors Need to Know
Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
XRAY Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
DENTSPLY SIRONA's customer-centric innovation and operational efficiency drive its first-quarter 2025 performance despite global macroeconomic challenges.
Dentsply (XRAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President, Investor Relations Simon Campion - Chief Executive Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Dylan Finley - UBS David Saxon - Needham & Company Jon Block - Stifel Jeff Johnson - Baird Jason Bednar - Piper Sandler Brandon Vazquez - William Blair Erin Wright - Morgan Stanley Operator Welcome to the Q1 2025 Dentsply Sirona Earnings Conference Call. At this time, all participants are in a listen-only mode.
Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.42 per share a year ago.
Stay Ahead of the Game With Dentsply (XRAY) Q1 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Dentsply (XRAY) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
